Media stories about Stericycle (NASDAQ:SRCL) have been trending somewhat positive on Wednesday, Accern Sentiment Analysis reports. The research firm identifies negative and positive media coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Stericycle earned a daily sentiment score of 0.17 on Accern’s scale. Accern also assigned news coverage about the business services provider an impact score of 45.6011642128461 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

Here are some of the news articles that may have impacted Accern Sentiment’s rankings:

Shares of Stericycle (NASDAQ SRCL) traded down $0.72 during trading on Wednesday, reaching $65.78. The company had a trading volume of 1,168,734 shares, compared to its average volume of 824,880. Stericycle has a 52-week low of $61.25 and a 52-week high of $88.00. The firm has a market capitalization of $5,750.72, a PE ratio of 15.52, a P/E/G ratio of 1.64 and a beta of 0.16. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.93.

Stericycle (NASDAQ:SRCL) last issued its earnings results on Wednesday, November 8th. The business services provider reported $1.10 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.14 by ($0.04). Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.93%. The firm had revenue of $883.00 million during the quarter, compared to analyst estimates of $896.81 million. During the same quarter in the previous year, the business posted $1.24 EPS. Stericycle’s revenue was down .8% compared to the same quarter last year. analysts predict that Stericycle will post 4.49 EPS for the current fiscal year.

Several equities analysts have weighed in on SRCL shares. William Blair reissued an “ourperform” rating on shares of Stericycle in a research report on Thursday, September 14th. Royal Bank Of Canada lowered their price objective on Stericycle from $74.00 to $67.00 and set an “underperform” rating for the company in a research report on Thursday, November 9th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $85.00 price objective (down previously from $95.00) on shares of Stericycle in a research report on Thursday, November 9th. Zacks Investment Research downgraded Stericycle from a “hold” rating to a “sell” rating in a research report on Wednesday, October 4th. Finally, Jefferies Group set a $108.00 price objective on Stericycle and gave the company a “buy” rating in a research report on Tuesday, October 17th. Four investment analysts have rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $76.73.

In related news, Director Mark C. Miller sold 19,753 shares of Stericycle stock in a transaction on Monday, November 27th. The stock was sold at an average price of $63.33, for a total value of $1,250,957.49. Following the transaction, the director now owns 205,854 shares in the company, valued at $13,036,733.82. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders sold 79,012 shares of company stock worth $5,240,668 in the last quarter. 3.50% of the stock is owned by insiders.

ILLEGAL ACTIVITY WARNING: This news story was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another domain, it was stolen and reposted in violation of United States & international trademark and copyright law. The original version of this news story can be viewed at https://www.thecerbatgem.com/2017/12/06/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-stericycle-srcl-stock-price.html.

Stericycle Company Profile

Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.

Insider Buying and Selling by Quarter for Stericycle (NASDAQ:SRCL)

Receive News & Stock Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related stocks with our FREE daily email newsletter.